Become a Patron

Subscribe on
iTunes    Android
YouTube    RSS

Biomarkers: Ushering in an Age of More Personalized Medicine

by Chris Wood, Senior Analyst
Casey Research

Today, personalized medicine seeks to move away from the one-size-fits-all, trial-and-error approach that has defined drug R&D and patient treatment basically since the time of Galen of Pergamon in the 2nd century AD. It increasingly focuses on matching the biological characteristics of each person with the best treatment options available and dosing for them, and in the future even perhaps the development of specific drugs for specific patients.

Truth be told, the idea of personalized medicine is nothing new. Back in the late 1800s, Canadian physician Sir William Osler (who was one of the founding professors at Johns Hopkins Hospital and has been called the “father of modern medicine”) said, “Variability is the law of life, and as no two faces are the same, no two bodies are alike, and no two individuals react alike, and behave alike under the abnormal conditions which we know as disease.”

Continue Reading at…

Comments are closed.